Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Efavirenz and Ritonavir on Brain P-gp Activity
NCT01668147Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ritonavir, efavirenz in human immunodeficiency virus infection (HIV), sponsored by Washington University School of Medicine. Started Aug 2012; status: completed.
02
Drugs
ritonavirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01668147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01668147.